Ghrelin Expression in Mast Cells of Infant Lung with Respiratory Distress Syndrome

1. Grappone L, Messina F. Hyaline membrane disease or respiratory distress syndrome? A new approach for an old disease Lidia. Journal of Pediatric and Neonatal Individualized Medicine 2014; 3: e030263.Search in Google Scholar

2. Bitterman PB. Pathogenesis of fibrosis in acute lung injury. Am J Med 1992; 92: 39-43.10.1016/0002-9343(92)90606-CSearch in Google Scholar

3. Locci G, Fanos V, Gerosa C, Faa G. Hyaline membrane disease (HMD): the role of the perinatal pathologist. Review. Journal of Pediatric and Neonatal Individualized Medicine 2014; 3: e030255.Search in Google Scholar

4. Jo HS. Genetic risk factors associated with respiratory distress syndrome. Korean J Pediatr 2014; 57: 157-63.10.3345/kjp.2014.57.4.157Search in Google Scholar

5. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 2005; 85: 495-522.10.1152/physrev.00012.2004Search in Google Scholar

6. Wang G, Lee HM, Englander E, et al. Ghrelin-not just another stomach hormone. Regul Pept 2002; 105: 75-81.10.1016/S0167-0115(02)00012-5Search in Google Scholar

7. Hattori N. Expression, regulation and biological actions of growth hormone (GH) and Ghrelin in the immune system. Growth Horm IGF Res 2009; 19: 187-97.10.1016/j.ghir.2008.12.00119144554Search in Google Scholar

8. Stefanov I, Ananiev J, Ivanova K, et al. Distribution of Ghrelin-positive mast cells in rat stomach. Biotechnology & Biotechnological Equipment 2017; 31: 774-81.10.1080/13102818.2017.1326013Search in Google Scholar

9. Lambrecht BN, Hammad H. The airway epithelium in asthma. Nat Med 2012; 18: 684-92.10.1038/nm.273722561832Search in Google Scholar

10. Neil WS. Recent advances in our understanding of human host responses to tuberculosis. Respir Res 2001; 2: 157-163.10.1186/rr53200207311686880Search in Google Scholar

11. Yoshida T, Tuder RM. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev 2007; 87: 1047-82.10.1152/physrev.00048.200617615396Search in Google Scholar

12. Sinnamon MJ, Carter KJ, Sims LP, et al. A protective role of mast cells in intestinal tumorigenesis. Carcinogenesis 2008; 29: 880-86.10.1093/carcin/bgn04018258601Search in Google Scholar

13. Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med 2012; 18: 693-704.10.1038/nm.2755Search in Google Scholar

14. 14. Boesiger J, Tsai M, Maurer M, et al. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fc epsilon receptor I expression. J Exp Med. 1998; 188: 1135-45.10.1084/jem.188.6.1135Search in Google Scholar

15. Horsmanheimo L, Harvima IT, Jarvikallio A, et al. Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol 1994; 131: 348-53.10.1111/j.1365-2133.1994.tb08522.xSearch in Google Scholar

16. Gibbs BF, Arm JP, Gibson K, et al. Human lung mast cells release small amounts of interleukin-4 and tumour necrosis factor-alpha in response to stimulation by antiIgE and stem cell factor. Eur J Pharmacol 1997; 327: 73-78.10.1016/S0014-2999(97)89680-XSearch in Google Scholar

17. Leon A, Buriani A, Dal Toso R, et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 1994; 91: 3739-43.10.1073/pnas.91.9.3739Search in Google Scholar

18. Orinska Z, Maurer M, Mirghomizadeh F, et al. IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nat Med 2007; 13: 927-34.10.1038/nm1615Search in Google Scholar

19. Church MK, Levi-Schaffer F. The human mast cell. J Allergy Clin Immunol 1997; 99: 155-60.10.1016/S0091-6749(97)70089-7Search in Google Scholar

20. Abraham SN, Thankavel K, Malaviya R. Mast cells as modulators of host defense in the lung. Front Biosci 1997; 2: 78-87.10.2741/A176Search in Google Scholar

21. Lan RS, Stewart GA, Henry PJ. Role of protease-activated receptors in airway function: a target for therapeutic intervention? Pharmacol Ther 2002; 95: 239-57.Search in Google Scholar

22. Berger P, Girodet PO, Begueret H, et al. Tryptase-stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell chemotaxis. FASEBJ 2003; 17: 2139-41.10.1096/fj.03-0041fjeSearch in Google Scholar

23. Smith TJ, Hougland MW, Johnson DA. Human lung tryptase. Purification and characterization. J biol Chem 1984; 259: 11046-51.10.1016/S0021-9258(18)90620-4Search in Google Scholar

24. McDonald DM, Schoeb TR, Lindsey JR. Mycoplasma infections cause long-lasting potentiation of neurogenic inflammation in the respiratory tract of the rat. J Clin Invest 1991; 87: 787-99.10.1172/JCI1150823298661999495Search in Google Scholar

25. Shimada K, Chen S, Dempsey PW, et al. The NOD/RIP2 Pathway Is Essential for Host Defenses Against Chlamydophila pneumoniae Lung Infection. PLoS Pathog 2009; 5: e1000379.10.1371/journal.ppat.1000379266027319360122Search in Google Scholar

26. Rodriguez N, Fend F, Jennen L, et al. Polymorphonuclear neutrophils improve replication of Chlamydia pneumoniae in vivo upon MyD88-dependent attraction. J. Immunol 2005; 174: 4836-44.10.4049/jimmunol.174.8.483615814710Search in Google Scholar

27. Crother TR, Ma J, Jupelli M, et al. Plasmacytoid dendritic cells play a role for effective innate immune responses during Chlamydia pneumoniae infection in mice. PLoS One 2012; 7: e48655.10.1371/journal.pone.0048655348537423119083Search in Google Scholar

28. Pesci A, Majori M, Piccoli ML, et al. Mast cells in bronchiolitis obliterans organizing pneumonia. Mast cell hyperplasia and evidence for extracellular release of tryptase. Chest 1996; 110: 383-91.10.1378/chest.110.2.3838697838Search in Google Scholar

29. Fisher MM, Baldo BA. Mast cell tryptase in anaesthetic anaphylactoid reactions. British Journal of Anaesthesia 1998; 80: 26-9.10.1093/bja/80.1.269505773Search in Google Scholar

30. Bradding P, Walls AF, Holgate ST. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 2006; 117: 1277-84.10.1016/j.jaci.2006.02.03916750987Search in Google Scholar

31. Volante M, Fulcheri E, Allìa E, et al. Ghrelin expression in fetal, infant, and adult human lung. J Histochem Cytochem 2002; 50: 1013-21.10.1177/00221554020500080312133904Search in Google Scholar

32. Li B, Zeng M, He W, et al. Ghrelin protects alveolar macrophages against lipopolysaccharide-induced apoptosis through growth hormone secretagogue receptor 1a-dependent c-Jun N-terminal kinase and Wnt/β-catenin signaling and suppresses lung inflammation. Endocrinology 2015; 156: 203-17.10.1210/en.2014-153925337654Search in Google Scholar

33. Waseem T, Duxbury M, Ito H, et al. Exogenous Ghrelin modulates release of pro-inflammatory and anti-inflammatorycytokinesinLPS-stimulatedmacrophagesthroughdistinct signaling pathways. Surgery 2008; 143: 334-342.10.1016/j.surg.2007.09.039227804518291254Search in Google Scholar

34. Imazu Y, Yanagi S, Miyoshi K, et al. Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation. Eur J Pharmacol 2011; 672: 153-8.10.1016/j.ejphar.2011.09.18321996315Search in Google Scholar

35. Xu X, Zhang D, Lyubynska N, et al. Mast cells protect mice from Mycoplasma pneumonia. Am J Respir Crit Care Med 2006; 173: 219-25.10.1164/rccm.200507-1034OC266299016210667Search in Google Scholar

36. Hoek KL, Cassell GH, Duffy LB, et al. Mycoplasma pneumoniaeinduced activation and cytokine production in rodent mast cells. J Allergy Clin Immunol 2002; 109: 470-76.10.1067/mai.2002.12195111897994Search in Google Scholar

37. Aroni K, Voudouris S, Ioannidis E, et al. Increased angiogenesis and mast cells in the centre compared to the periphery of vitiligo lesions. Arch Dermatol Res 2010; 302: 601-07.10.1007/s00403-010-1040-920204655Search in Google Scholar